Bosphore® HBV Drug Resistance Mutation Sequencing Kit v1, is a Real-Time PCR-based in vitro diagnostic medical device, IVD CE marked according to 98/79/EC Directive. Bosphore® HBV Drug Resistance Mutation Sequencing Kit v1 analyzes the drug resistance mutations in the polymerase gene RT domain of the HBV DNA in human serum or plasma, encompassing all the HBV genotypes.
Bosphore® HBV Drug Resistance Mutation Sequencing Kit v1 includes HBV genotyping, analysis of RT domain mutations, SHB protein mutations and SHB protein Escape mutations and analysis of drug resistance mutations indicated below: Lamivudine, Zeffix®, Adefovir, Hepsera®, Entecavir, Baraclude®, Tenofovir DF, Telbivudine, Tyzeka®, Sebivo®.
We recommend our customers to sequence HBV samples above 500 IU/ml viral load.
©2021 Anatolia Tanı ve Biyoteknoloji Ürünleri Ar-Ge San. ve Tic. A.Ş. All Rights Reserved.